This is female nomination
Because of the particular specificity of products presented in this category, an objective evaluation and comment on the nominees is only allowed for women. Men can only see the results.
This is female nomination
Results
Celebrities Jury survey results of 2017 in category
Pharmaceuticals with no prescription / Medication for female intimate health
1. Tantum Rosa (DILEO Farma Ukraine)Link 33.33% 5
 
2.
3
Gynolakt (Teva)Link 22.22% 3.33
 
2. Vagisan (Ядран – Галенська Лабораторія д.д.)Link 22.22% 3.33
 
2.
~
Неотризол (ORGANOSYN)Link 22.22% 3.33
 
5.
~
Gynodek (YURiA-PHARM)Link 11.11% 1.67
 
5.
2
Gynoflor (Delta Medical)Link 11.11% 1.67
 
5.
2
Вагілак (Pharmascience)Link 11.11% 1.67
 
–.
~
Bioselac (Rotapharm)Link 11.11% 1.67
 
View results of current, 2024 year

Normed consumer's score are calculated by 5-score scale, accordingly to the methodic of the research.
Notice
The participant which took the 1st place in this rating is by opinion of celebrities panel is the best choice in 2017, recommendation of the celebrities #1 in the category “Medication for female intimate health”.
Using this rating is only possible with obligatory link to the source.
This rating was built as a result of the study of social preferences in 2017, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.  Details…
Comments(0)
all in a row | positive | negative

No comments yet… Be the first to leave comment on this topic!

or
You may sign in using:
Enter with Facebook Enter with Google Enter with VK
Aye Nay
  

Achtung! Please be polite! Although that modertors of this web-portal are excessively democratic, any unethical, unqotable or just rude expressions, which abuse other visitors of this web site, can be deleted. Also will be deleted any spam and public comments with private phone numbers.